Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytokinetics (CYTK) Exchange Rate Effect (2023 - 2025)

Cytokinetics (CYTK) has disclosed Exchange Rate Effect for 3 consecutive years, with -$632000.0 as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect changed N/A to -$632000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.0 million through Dec 2025, changed N/A year-over-year, with the annual reading at -$715000.0 for FY2025, 442.11% down from the prior year.
  • Exchange Rate Effect for Q4 2025 was -$632000.0 at Cytokinetics, down from -$270000.0 in the prior quarter.
  • The five-year high for Exchange Rate Effect was $27000.0 in Q1 2024, with the low at -$632000.0 in Q4 2025.
  • Average Exchange Rate Effect over 3 years is -$167500.0, with a median of -$73000.0 recorded in 2023.
  • Peak annual rise in Exchange Rate Effect hit 1100.0% in 2025, while the deepest fall reached 1100.0% in 2025.
  • Over 3 years, Exchange Rate Effect stood at -$20000.0 in 2023, then crashed by 530.0% to -$126000.0 in 2024, then tumbled by 401.59% to -$632000.0 in 2025.
  • According to Business Quant data, Exchange Rate Effect over the past three periods came in at -$632000.0, -$270000.0, and -$126000.0 for Q4 2025, Q1 2025, and Q3 2024 respectively.